Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC.

[1]  S. Du,et al.  Using Dynamic 99mTc-GSA SPECT/CT Fusion Images for Hepatectomy Planning and Postoperative Liver Failure Prediction , 2015, Annals of Surgical Oncology.

[2]  Kyung-Suk Suh,et al.  Feasibility of three-dimensional virtual surgical planning in living liver donors , 2015, Abdominal Imaging.

[3]  Jean-Luc Daire,et al.  Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. , 2015, Radiology.

[4]  Joon Koo Han,et al.  Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. , 2015, Radiology.

[5]  A. Ba-Ssalamah,et al.  Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. , 2014, Radiology.

[6]  Joon Koo Han,et al.  Monopolar Radiofrequency Ablation Using a Dual-Switching System and a Separable Clustered Electrode: Evaluation of the In Vivo Efficiency , 2014, Korean journal of radiology.

[7]  B. Choi,et al.  Dual Switching Monopolar Radiofrequency Ablation Using a Separable Clustered Electrode: Comparison with Consecutive and Switching Monopolar Modes in Ex Vivo Bovine Livers , 2013, Korean journal of radiology.

[8]  Seonwoo Kim,et al.  Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[9]  A. Schinkel,et al.  Hepatocyte Hopping of OATP1B Substrates Contributes to Efficient Hepatic Detoxification , 2012, Clinical pharmacology and therapeutics.

[10]  A. Ruzzenente,et al.  How Much Remnant Is Enough in Liver Resection? , 2012, Digestive Surgery.

[11]  J. Prieto,et al.  Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. , 2012, Journal of hepatology.

[12]  Kunio Doi,et al.  Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. , 2011, Radiology.

[13]  M. Schultze-Mosgau,et al.  Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment , 2011, Investigative radiology.

[14]  H. Nilsson Magnetic resonance imaging for the assessment of liver function , 2011 .

[15]  Jürgen Weitz,et al.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). , 2011, Surgery.

[16]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[17]  T. Gruenberger,et al.  Evaluation of Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastases Using Indocyanine Green Clearance Testing , 2011, Annals of Surgical Oncology.

[18]  A. Nordell,et al.  Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[19]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[20]  M. Niemi,et al.  Impact of OATP transporters on pharmacokinetics , 2009, British journal of pharmacology.

[21]  A. Nordell,et al.  Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte‐specific contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[22]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[23]  M. Vivarelli,et al.  Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  O. Farges,et al.  The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[25]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[26]  Heather Rhule,et al.  The Process of Evaluation and Documentation of Crash Test Dummies for Part 572 of the Code of Federal Regulations , 2005 .

[27]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[28]  L. Ellis,et al.  Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients , 2004, Annals of Surgical Oncology.

[29]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[30]  K. Zou,et al.  Correlation and simple linear regression. , 2003, Radiology.

[31]  N. Furumoto,et al.  Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. , 2001, Archives of surgery.

[32]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[33]  Y. Matsui,et al.  Preoperative determination of the surgical procedure for hepatectomy using technetium‐99m‐galactosyl human serum albumin (99mTc‐GSA) liver scintigraphy , 1997, Hepatology.

[34]  G. T. Krishnamurthy,et al.  Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.